Communication Strategies & HIPPA

 What electronic communication strategies are used at your organization to communicate with patients? Based on your organization’s HIPAA policy, how is patient privacy and confidentiality protected?

Submission Instructions:

  • Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources

Maternity Nursing

 

#1  A 35 year old G1P0 is 20 weeks gestation with a past medical history of hypertension.  Her pregnancy has been uneventful; however, at today’s appointment, her blood pressure was 150/100mmHg at first check and 15 minutes later was still 136/90 mmHg.  She is also complaining of light-headedness and palpitations.

     A.  What actions would you take as her nurse?

     B.  What change should this patient be encouraged to do?

     C.  What are the expected outcomes?

#2.  The patient is a 17 year old female who arrives to the emergency department in active labor with a questionable past of obstetrical history.  She indicates that she has had no prenatal care, does not remember her last menstruation period, and is evasive if this is her first pregnancy.  Blood work indicates she is Rh negative.

     A.  What are some concerns you as her nurse should be prepared for?

     B.  What teaching does this patient need?

     C.  What are the expected outcomes for this patient?

#3  A 15 year-old female has come to the urgent care complaining about nausea, vomiting, and feeling tired all the time.  Her complaints are vague, but the nurse is suspicious she may be pregnant when the girl mentions she is late for her period.

     A.  What nursing care will you provide to this young lady if she is pregnant.

     B.   What nursing diagnoses will apply to this situation?

     C.  What are some expected outcomes?

#4 A woman in labor has been progressing well with minimal difficulties.  The nullipara woman has been working with her coach, progressing through the process.  The fetal monitor has indicated that the fetus is in stable condition.  Suddenly, the monitor alarm goes off and exam reveals a possible prolapsed cord.

     A.  What steps should you take as her nurse?

     B.  What care does the mother and infant need?

     C. How would you evaluate that your interventions were helpful?

#5  Your patient is a petite 23-year-old G1P0 woman.  Prenatal assessment has determined that this woman will need a cesarean birth due to cephalopelvic disproportion.

     A.  What can this patient and you as the nurse do prenatally to ensure a safe delivery?

     B.  What potential risks and/or complications should the nurse be aware of and prepare for?

     C.  What postoperative care will this mother and/or infant need?

Community Assessment and Analysis Presentation

The RN to BSN program at Grand Canyon University meets the requirements for clinical competencies as defined by the Commission on Collegiate Nursing Education (CCNE) and the American Association of Colleges of Nursing (AACN), using nontraditional experiences for practicing nurses. These experiences come in the form of direct and indirect care experiences in which licensed nursing students engage in learning within the context of their hospital organization, specific care discipline, and local communities.

This assignment consists of both an interview and a PowerPoint (PPT) presentation.

Assessment/Interview

Select a community of interest in your region. Perform a physical assessment of the community.

  1. Perform a direct assessment of a community of interest using the “Functional Health Patterns Community Assessment Guide.”
  2. Interview a community health and public health provider regarding that person’s role and experiences within the community.

Interview Guidelines

Interviews can take place in-person, by phone, or by Skype.

Develop interview questions to gather information about the role of the provider in the community and the health issues faced by the chosen community.

Complete the “Provider Interview Acknowledgement Form” prior to conducting the interview. Submit this document separately in its respective drop box.

Compile key findings from the interview, including the interview questions used, and submit these with the presentation.

PowerPoint Presentation

Create a PowerPoint presentation of 15-20 slides (slide count does not include title and references slide) describing the chosen community interest.

Include the following in your presentation:

  1. Description of community and community boundaries: the people and the geographic, geopolitical, financial, educational level; ethnic and phenomenological features of the community, as well as types of social interactions; common goals and interests; and barriers, and challenges, including any identified social determinates of health.
  2. Summary of community assessment: (a) funding sources and (b) partnerships.
  3. Summary of interview with community health/public health provider.
  4. Identification of an issue that is lacking or an opportunity for health promotion.
  5. A conclusion summarizing your key findings and a discussion of your impressions of the general health of the community.

While APA style is not required for the body of this assignment, solid academic writing is expected, and documentation of sources should be presented using APA format ting guidelines, which can be found in the APA Style Guide, located in the Student Success Center.

This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.

Ethical Considerations

 

As we have discovered over the past few weeks, the U.S. has continued to see increasing incidence of diabetes as one of the top eight disease burdens.  The prevalence has increased globally with a ranking of 3rd in 2016 for the leading cause of disabilities in the U.S. (The U.S. Burden of Disease Collaborators, 2018). This is even more alarming with the world’s aging population who is at greater risk for developing diabetes and the multitude of complex complications.  Adults 60 years or older often have higher co-morbidities secondary to age that when combined with diabetes lead to diabetes-related conditions, such as myocardial infarctions, lower extremity amputations,  renal disease, cognitive impairment and dementia, and visual disturbances, which place them at higher risks for death and disability (Valencia et al., 2018). Diabetes management continues to be essential in the prevention of diabetes related complications. Evidence has shown that diabetes self-management, medication management, dietary compliance and exercise, and patient education continue to be primary interventions in the management of this complex disease. However, as these have not demonstrated improvements in glycemic control or prevention of hypoglycemic serious events, the need to add additional interventions utilizing technology are warranted.  One such intervention is the addition of continuous glucose monitoring in both type 1.

Continuous glucose monitoring (CGM) has arisen over the last decade initially as an adjunct treatment to finger sticks and A1C monitoring (Hirsch et al., 2019).  In response to patient preference, compliance with treatment and monitoring plans, quality of monitoring, and cost effectiveness, more studies and evaluation of CGM has emerged. In addition, the need to prevent serious complications related to hypoglycemic events also led to more research and trials in the use of continuous glucose monitoring (Bergenstal, 2018).   

In our organization, most patients do not continue using their insulin pumps or continuous glucose monitors during acute events in the hospital. Implementation of a research-based intervention such as CGM for Type 1 diabetics would allow for stabilization of patient glucose levels and prevent serious complications related to hypoglycemia that we often have seen.

What are the potential benefits and harms related to your selected practice problem when considering a research-based intervention for your practice change project?

The use of CGM in diabetes is believed to allow for several benefits. First, it can assist in the prevention of hypoglycemia in patients who often are not aware of extreme drops in glucose levels.  Routine finger glucose sticks were often the standard in diabetic monitoring but were not always performed as scheduled or felt to be of high importance to adults with diabetes. CGM allows for real time data to be reviewed by patients; can identify quick changes in the patient’s glucose levels with meals or exercise and warns patients of hypoglycemic events that may otherwise have been unnoticed (Bergenstal, 2018).  Studies have shown that the use of CGM has allowed for better control of A1C levels, less time in hyperglycemic events, and decreased incidences of severe hypoglycemic events (Hirsch, et al., 2019).  Using the CGM during the hospitalization allows for monitoring of glucose levels during times of stress and acute illness and can be essential in the prevention of hyper-hypo events during periods of NPO status related to diagnostic testing.

Studies have shown some concerns related to CGM especially in the use of older adults. First, as with any new technology, patients must receive product instructions and all educational information related to the therapy.  To perform this implementation, several guidelines to ensure safe and ethical patient practices must be followed. Our goals for the intervention should answer clear questions regarding the purpose and benefits that CGM will provide to our patients. Patients are to be provided education regarding the monitoring that will occur and should have their privacy maintained, updated on any changes in their treatment plan, and monitored closely for any adverse effects during their hospitalization (NIH).  Older patients may not have a clear understanding of this advanced treatment or how the use of smart phones or recording devices work. They may need additional education and support while hospitalized.  

Are there competing personal or professional values related to this research-based intervention that might impact the implementation of this intervention in your practice setting?

There are several types of devices that could be used our intervention. We would wish to reduce bias and evaluate the benefits and impediments of various models prior to implementation.  Cost effective monitors would be preferred but not at the expense of utilizing a poorly reviewed technology that does not have quality outcomes for our patients. In review of types of CGM, there are newer models that are inserted into the subcutaneous tissue and allow for quick removal if needed. Previous studies show these to be effective and safe for insulin dosing but do need further evaluation of hypoglycemic events (Elshimy & Correa, 2020).  As it would be necessary to ensure accuracy of glucose levels via the continuous monitors, fingersticks, and lab draws may still be needed. Patients may be confused as to why they are receiving multiple interventions. We would wish to reduce patient fears and anxiety by supporting and re-educating as needed.

In addition, education to nursing staff and providers is essential prior to implementation of this intervention.  With some current challenges with nurse staffing in our organization, there may be barriers to nurse buy-in with additional tasks being assigned to them during the trial. I would wish to ensure that nurses understand the reason for the trial and can engage in their importance to prevent events of hypoglycemia and improve patient outcomes.

What types of objections might be raised? How will you explain your decision to key stakeholders to address these objections?

Some objections related to the intervention may be related to the inexperience and knowledge of providers and nursing staff. Some may find the process to perform the data retrieval as difficult or as added tasks to the workload. There may also be barriers related to cost and accuracy. Sharing that CGM has noted accuracy of a 10% absolute difference when compared to capillary glucose results may reduce these concerns (Elshimy & Correa, 2020).  Training superusers to better understand the CGM, provide education to patients, and insert the monitor can assist with workflow and quality controls during the hospitalization (Hirsch et al.., 2019).  In addition, the cost of this intervention may be covered by insurance or Medicare dependent upon the patient’s current diabetes management.   

The continuation of a CGM is shown to improve glycemic control for patients and could be worn for up to 14 days. This could provide clearer results for primary care physicians upon retrieval after discharge.  There would be the need to continue patient education and understanding related to care for the monitor as well as any self-management interventions based upon glucose results.  Education on the monitor screen and retrieval of results would be needed.  If older or cognitively challenged patients have difficulties with manipulation or understanding of the CGM, it may require removal and return to standard treatment modality and fingersticks may be needed. Teach-back for patient education is necessary in the evaluation for safe glucose monitoring and care after discharge (Hirsch et al., 2019).

Diabetes continues to be a leading healthcare concern and relies upon various modalities of self care in the maintenance of glucose levels.  Using continuous glucose monitoring while in the hospital could prevent episodes of hypoglycemia that many diabetics are prone to during acute illness. There is evidence that this intervention has been successful in maintaining glucose control in type 1 diabetics and is being evaluated more often now in the treatment for type 2 as well. 

I need a comment for this discussion board at least 2 paragraphs and 2 sources no later than 5 years.

Discussion 3

  • WHEN WAS PRESCRIPTION AUTHORITY FOR APRN APPROVED, SPECIFICALLY IN FLORIDA?
  • WHICH ARE THE REQUIREMENTS FOR THE APRN BE GRANTED AUTHORIZATION/PRIVILAGES TO PRESCRIBED CONTROLLED SUBSTANCE?
  • WHAT IS CONSIDERED CONTROLLED SUBSTANCE?
  • HOW TO APPLY FOR DEA NUMBER?
  • VISIT THE CDC WEBSITE, AND ELABORATE ON THE CURRENT ISSUE WITH CONTROLLED SUBSTANCE ABUSE IN THE USA AND FLORIDA?

https://floridasnursing.gov/new-legislation-impacting-your-profession/

https://www.flmedical.org/Florida/Florida_Public/Docs/FMA-Opioid-HB21.pdf

https://fnpn.enpnetwork.com/nurse-practitioner-news/133651-dea-licensure-information-for-florida-

https://www.cdc.gov/drugoverdose/prescribing/guideline.html

https://www.cdc.gov/drugoverdose/data/index.html

Psychiatric Health

Using these diagnosis, impulses control disorder, Adjustment disorder, Substance or addictive disorder, Sleep disorder and personality disorder to formulate 5 psychiatric cases, and treatment approaches with a very brief summary of client visit and demographics. One page.